VYNE Therapeutics Inc. (NASDAQ:VYNE) up 10% in a month. Recently the company established a Scientific Advisory Board comprising leading clinicians and scientists that specialize in inflammatory and immunological diseases. Market Stats On Friday, VYNE stock fell 0.72% at $1.37 with more than 442k shares, compared to its average volume of 898K shares. The stock has …
Continue reading “VYNE Therapeutics Inc. (NASDAQ:VYNE) Stock Gains Momentum: Jumps 10% in a Month”